The structure-based design of a mutant form of the thromboxane A 2 prostanoid receptor (TP) was instrumental in characterizing the structural determinants of the hetero-dimerization process of this G protein coupled receptor (GPCR). The results suggest that the heterodimeric complexes between the TPa and b isoforms are characterized by contacts between hydrophobic residues in helix 1 from both monomers. Functional characterization confirms that TPa-TPb hetero-dimerization serves to regulate TPa function through agonist-induced internalization, with important implications in cardiovascular homeostasis. The integrated approach employed in this study can be adopted to gain structural and functional insights into the dimerization/oligomerization process of all GPCRs for which the structural model of the monomer can be achieved at reasonable atomic resolution.
Introduction
G protein coupled receptors (GPCRs) comprise the largest family of signal transducing proteins that account for up to 40% of the total targets for existing drugs (reviewed in [1] ). Emerging evidence suggests that many GPCRs exist as homo-and/or hetero-assemblies of two or more monomers [2, 3] . The thromboxane A 2 receptor (TP) is not an exception, as in vitro evidence has shown that the a and b isoforms of this GPCR form homodimers and heterodimers independently from their functional state (this study and the papers from [4, 5] , as well as heterodimers with other prostanoid GPCRs [6, 7] . Owing to the key roles played by TP for maintaining cardiovascular homeostasis as well as for its involvement in major cardiovascular events, such as myocardial infarction, thrombosis, and altered vessel wall reactivity [8] , it is essential to shed some light on the role of dimerization/oligomerization in the functioning and regulation of this receptor.
In spite of the evidence that rhodopsin and the b 2 -adrenergic receptor (b2-AR) activate their cognate G protein in the monomeric form [9] [10] [11] [12] and that supramolecular organizations of rhodopsin [9] , neurotensin 1 receptor [13] and leukotriene B 4 receptor (BLT 2 ) [14] reduce G protein coupling, formation of GPCR oligomers in living cells has been widely demonstrated [15] [16] [17] . Indeed, it was recently inferred that the b 2 -AR exists in dynamic equilibrium between monomeric and higher-order oligomers, with the average size of the oligomer being a tetramer and with inverse agonists promoting higher order oligomerization [15] . The occurrence of oligomeric complexes involving GPCRs and intracellular and extracellular proteins would imply that conformational changes occurring in one receptor molecule in response to ligand binding may be transmitted to others within the multimolecular complex. The conformational changes transmitted by direct proteinprotein interactions may represent a first level of regulation of a receptor. The biological role(s) of homologous and heterologous receptor aggregation is/are, however, far from being clarified [18] [19] [20] . Likewise, knowledge about the most likely architectures of GPCR dimers is still illdefined. Sequence-and docking-based approaches investigated dimerization in different GPCRs highlighting the involvement of different helices in the inter-monomer interfaces, with emphasis on helix 4 (H4) [21] . System's dependent variety in the dimer architecture emerges also from results of in vitro experiments. In this respect, the highest resolution information available thus far comes from X-ray crystallography and atomic force microscopy (AFM) measurements on rhodopsin, opsin, b 2 -AR and CXCR4 chemokine receptor, as well as from cysteine crosslinking experiments on D 2 receptor (D 2 R), and disulphide trapping experiments on 5HT 1c receptor [22] [23] [24] [25] [26] [27] [28] [29] . With regard to rhodopsin, the geometrical constraints from AFM measurements led to the proposal of a semi-empirical model of a higher order rhodopsin structure [22] . According to this model, two monomers of rhodopsin interact with each other through the second extracellular loops (EL2), the second cytoplasmic loops (IL2), and H4 and H5 of both monomers. However, rhodopsin crystals obtained under different experimental conditions showed alternative dimeric architectures characterized by H1-H1 or H8-H8 contacts all compatible with the AFM images [23] . A similar architecture was also found for the opsin apoprotein [28] . With respect to the b 2 -AR, crystal packing in the presence of cholesterol shows a significant involvement of the hydrophobic molecule in the intermonomer interface [24] . In this framework, protein-protein contacts are minimal and include a pair of salt bridges between K60
(1.59) (the first number in parenthesis refers to the helix and the following indicate the position of the helical residue relative to the most highly conserved residue within that helix, here denoted as 50, according to the nomenclature proposed by Ballesteros and Weinstein [30] ) and E338 from H8 [24] . The crystal structure of CXCR4 in complex with either a small molecule or the CVX15 cyclic peptide antagonist shows a dimer interface essentially contributed by amino acids from the extracellular halves of H5 and H6, with emphasis on the former [29] . Additional contacts involving the cytosolic ends of H3, H4 and IL2 are shown by the CXCR4 complex with the cyclic peptide [29] . For the D 2 R, cysteine crosslinking experiments interpreted in the context of the structural models highlighted the potential rearrangements of the dimer architecture depending on the receptor functional state, the H4-H5 and H4-H4 contact dimers being, respectively, associated with inactive and active states [25, 26] . In a more recent study, the same authors provided evidence that D 2 R forms higher-order oligomers in living cells and that H1 and H8 form a second symmetric interface in addition to the previously identified H4 interface [16] . The involvement of H1/H8 GPCR oligomerization has been recently proposed for the b 2 -AR as well [15] . Finally, recent in vitro disulphide-trapping experiments on the 5HT 2c receptor suggest the existence of dimer architectures insensitive and sensitive to the functional states of the receptor [27] . In this respect, state-insensitive architectures would involve H1-H1 contacts, whereas state-sensitive architectures would be characterized by H4-H5 contacts [27] . Collectively, consensus emerges on H1, H4 and H5 being involved in GPCR dimerization/oligomerization.
In this study, we predicted the presumable contacts in TP dimers by means of an approach based on docking simulations [31] . Quaternary structure predictions were challenged by in vitro site-directed mutagenesis, immunofluorescence, fluorescence resonance energy transfer (FRET), ligand binding and signaling experiments. In vitro experiments validated the predictions of computational experiments indicating that TPa-TPb heterodimers are mediated by H1-H1 contacts.
Experimental procedures

Materials and methods
Cell-culture media, supplements and sera, and molecular biological reagents, including high fidelity Taq and PCR reagents, were purchased from Invitrogen (San Giuliano Milanese, Italy). Epicurian Coli DH5a competent cells were from Stratagene (La Jolla, CA, USA). Restriction and modification enzymes were purchased from Fermentas/ M-Medical (Milan, Italy). Oligonucleotides were synthesized by PRIMM (Milan, Italy) and DNA sequencing was performed by Consorzio di Genetica Molecolare (Monza, Italy 
Computational experiments
Computational experiments consisted in rigid body docking simulations of TPa receptor homodimerization, following a recently reported computational protocol [31] [32] [33] . The computational modeling of the TPa receptor is described in detail in a recent publication [34] and consists of comparative modeling followed by ns molecular dynamics (MD) simulations in implicit membrane [34] .
In this study, the following structural models of the empty form of the wild-type TP were considered for docking simulations: the selected input structure [(WT Inp , Table 1 ), i.e., prior to energy minimization and MD simulation], the energy minimized structure (i.e., prior to MD simulations, WT Min , Table 1 ), the minimized structures averaged over the first, central and last 2 ns (i.e., WT AVGf2ns , WT AVGc2ns and WT AVGl2ns , respectively, Table 1 ) as well as the minimized structure averaged over the whole 4-ns trajectory (i.e., WT AVG4ns , Table 1 ).
Rigid-body docking simulations were carried out by means of the ZDOCK 2.1 software [35] , following the same protocol detailed in a methodological article [31] In this respect, two identical copies of each structural model were docked together, i.e., one monomer was used as a fixed protein (target) and the other as a mobile protein (probe). A rotational sampling interval of 6°was employed, i.e., dense sampling, and the best 4,000 solutions were retained and ranked according to the ZDOCK score (ZD-score). These solutions were subjected to a filter, the ''membrane topology'' filter, which discards all the solutions that violate the membrane topology of the protein. For the membrane topology filter to work properly, the two docked structural models must have the appropriate orientation with respect to the putative membrane. This is due to the fact that ZDOCK expresses its docking solutions in terms of a x, y, z-translation and a R z R x R z -rotation of the probe. If both target and probe are properly oriented in a membrane parallel to the XY plane, the translation along the z-axis can be considered as an offset out of the membrane and the R x component of the rotation as a deviation from the original orientation in the membrane. Indeed the filter discards all the solutions characterized by a deviation angle from the original z-axis, i.e., tilt angle, and a displacement of the geometrical center along the z-axis, i.e., z-offset, above defined threshold values. For the tilt angle and the z-offset, thresholds of 0.6 radians and 6.0 Å were, respectively, employed. The filtered solutions from each run were merged with the target protein, leading to an equivalent number of dimers that were subjected to cluster analysis. The Ca-root mean square deviation (Ca-RMSD) threshold for each pair of superimposed dimers was set equal to 3.0 Å . All the amino acid residues in the dimer were included in Ca-RMSD calculations. Since the filter cutoffs were intentionally quite permissive to avoid removal of reliable solutions, due to possible small deviations of the initial orientation from the proper membrane topology, inspection of the cluster centers served to finally discard the remaining unreliable solutions. The predicted dimers were energy refined, following the same energy minimization setup as the one employed for the receptor monomer. The same docking protocol was also applied to a mutated form of WT AVG4ns carrying alanine substitutions for I25 (1.33) , W29 (1.37) , C35 (1.43) , V36 (1.44) , L39 (1.47) , L43
(1.51) , L44 (1.52) and S47 (1.55) . In this respect, two docking simulations were carried out, one using mutated TP as a target and wild-type TP as a probe, and the other using mutant TP both as a target and as a probe.
Introduction of N-terminal epitope tags
The cDNAs of TPs were subcloned from the original pcDNA3 expression vectors into the pGW1 vector (kindly PCR products were digested using AscI and EcoRI restriction enzymes and inserted into the purified expression vector of interest that had been opened between the AscI/EcoRI polylinker sites using the respective enzymes. The resulting constructs were verified by sequencing.
Site-directed mutagenesis
Specific base substitutions were introduced into the cDNAs of TPs using a cDNA specifically synthesized by Geneart (Regensburg, Germany) to generate the corresponding TPa and TPb TM1 mutant isoforms, each carrying the amino acids I25 (1.33) , W29 (1.37) , C35 (1.43) , V36 (1.44) , L39 (1.47) , L43
(1.51) , L44 (1.52) and S47 (1.55) in H1 replaced by alanines. The resulting constructs were verified by sequencing.
Culture and transfection of HEK293T cells HEK293T cells were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% (v/v) fetal bovine serum (FBS), 2 mM glutamine, 50 units/ml penicillin, 100 lg/ml streptomycin at 37°C in a humidified atmosphere of 95% air and 5% CO 2 . Transfections were performed using the FuGENE6 reagent (Roche Diagnostics, Milan, Italy) following manufacturer's instructions. Briefly, cells were seeded onto tissue culture dishes previously coated with 10 lg/ml poly-D-lysine, and transfected at 50-60% confluency with an optimized 3:1 FuGENE 6/DNA ratio. All analyses were performed 48 h after transfection.
Immunofluorescence microscopy
Transfected cells on coverslips were incubated for 1 h with anti-Myc or anti-HA antibodies under non-permeabilizing conditions in the absence or presence of U46619 agonist (10 -6 M) in DMEM plus 10% FBS at 37°C. , and mounted on glass slides with a 90% (v/v) glycerol/PBS solution. Samples were analyzed using Zeiss LSM 710 confocal laser-scanning microscope (Jena, Germany). Receptor co-internalization was calculated as the ratios between the average intensities of cytoplasmatic total fluorescence in each cell. Statistical analysis was performed on 30 cells for each experimental condition from three independent transfections.
Acceptor photobleaching FRET
The FRET measurements were performed with the laserinduced acceptor bleaching method previously reported [36] . Briefly, cells co-transfected with wild-type or mutant HA-and Myc-tagged TP pairs were incubated for 1 h with the anti-tag antibodies, fixed and exposed to fluorochromeconjugated secondary antibodies. All images were acquired with the laser scanning confocal microscope using a 639 oil-immersion objective applying an additional 1.5-29 zoom. Before bleaching, three images were captured in the 488-nm (donor fluorochrome wavelength) and the 561-nm (acceptor fluorochrome wavelength) channels using the line-by-line sequential mode without any averaging steps to reduce basal bleaching. Then, the defined plasmalemmal region of interest (ROI) was bleached by 20 pulses of full power 561-nm laser line (each pulse 1.28 ls/pixel). After bleaching seven images were acquired to obtain a full curve for analysis. The number of bleaching steps was held constant throughout each experiment. FRET was quantified by measuring the average intensities of ROIs in the donor and acceptor fluorochrome channels before and after bleaching using the NIH ImageJ software (http:// rsbweb.nih.gov/ij/). To determine any change of fluorescence intensities not due to FRET occurring during the measurements, a distinct membrane 'sentinel' ROI of approximately the same size of the bleached ROI was measured in parallel, and all the results were normalized according to the background bleaching recorded in the sentinel ROI. Proper controls were performed to verify that no artifacts were generated in the emission spectra throughout the experimental setup due to sample overheating. Twenty measurements from two different transfections were performed for each experimental condition. Total inositol phosphate production Signaling of TPs was assessed by measuring the accumulation of total IPs as previously described [37, 38] . Briefly, cells labeled overnight with 0.5 lCi of myo- [2- 3 H]inositol (18 Ci/mmol) were pre-incubated with 25 mM LiCl for 10 min followed by incubation with increasing concentrations of the TP selective U46619 agonist for 30 min at 37°C. The reaction was terminated by removal of the medium. Total IPs were extracted with 10 mM formic acid for 30 min, neutralized with 5 mM NH 4 OH, pH 8-9, and purified by anion exchange chromatography through AG 1X-8 resin, formate form, 200-400 mesh.
Statistical analysis
Analysis of ligand binding data was performed by implementing in Prism 4 (GraphPad Software Inc., San Diego, CA, USA) the model described in the LIGAND software [39] . Statistical analysis of the concentration-response curves was performed with Prism 4 using the four-parameter logistic model, as described in the ALLFIT program [40] . Errors are expressed as percent coefficient of variation (%CV) and calculated by simultaneous analysis of at least two independent experiments performed with duplicate determinations. All curves were fitted by computer.
Statistical analysis of immunofluorescence data was performed using Student t test or one-way ANOVA repeated measurements with one grouping factor.
Data are expressed as means ± SD. A level of statistical significance of p \ 0.05 was accepted.
Results
Predictions of likely interfaces in TP dimers
Computational experiments were carried out on structural models of TPa. This isoform (343 residues) shares the first 328 amino acids with TPb (407 residues). The exclusion of TPb from computational experiments was dictated by difficulties in modeling the 344-407 C-terminal portion that lacks homology with the rhodopsin template. Our choice to focus on TPa is also justified by the founded expectation that quaternary structure predictions on TPa are also valid for TPb since the structural differences between the two isoforms are limited to the last 15 amino acids of TPb that unlikely participate in inter-monomer contacts. Predictions were carried out by a computational approach based upon rigid-body docking, ad hoc filtering, automatic cluster analysis and visual inspection of the cluster centers (i.e., the structure with the highest number of neighbors in a cluster) (see Materials and methods [31] ). In order to corroborate predictions, docking simulations were carried out on six different structural models of the empty wild-type receptor (Table 1 , see also Methods).
Collectively, the docking solutions that passed the membrane topology-based filter (i.e., the realistic solutions) range from a minimum of 65 to a maximum of 125 out of the 4,000 collected from each run (Table 1) , thus representing on average about 2% of the total output solutions (i.e., the best solutions according to the docking score (ZD-score). Since the filtering conditions were intentionally quite permissive (see Materials and methods), inspection of the cluster centers finally served to discard the remaining low reliable solutions. Following this final filtering the percentage of reliable solutions decreased on average to 0.7%. For all the docking simulations on the different average minimized structures, more than 60% of such reliable solutions are characterized by H1-H1 contacts. Among them, the best solutions (i.e., according to the docking score) fall among the first 100 out of 4,000, and share a common architecture of the inter-monomer interface, characterized by H1-H1 and, to a lower extent, by H1-H2,EL1 and H8-H8 contacts (Table 1 , Supplementary Figure 1 (Figure S1) ). This is true for all the forms except WT AVGF2ns for which the best solution has a rank number 154 and is characterized by lack of H8-H8 contacts ( Figure S1C ). The predicted interface involves also contacts between a limited number of amino acids from the N-terminus (Fig. 1) . Most of the inter-monomer contacts involve hydrophobic amino acids on transmembrane H1 (TM1) from both dimers. Monomers A and B in the predicted dimer (i.e., docking solution N. 30, Table 1 ; Figs. 1, S1F) bury 1,412 and 1,418 Ǻ 2 of surface, respectively. The contribution of N-ter, H1, H2, E1, and H8 to the total buried surface area in the predicted monomer is 11.62, 33.07, 18.20, 15.41, and 21.70%, respectively.
Alanine replacements of the H1 amino acids participating in inter-monomer interface in the predicted dimer, i.e., I25 (1.33) , W29 (1.37) , C35 (1.43) , V36
( number and docking scores of the reliable solutions. In particular, docking simulations using mutant TP as a target and WT TP as a probe, found the same docking solution as simulations on the corresponding wild-type form but with a decreased docking score (i.e., solution N. 195 was the best one). On the other hand, docking simulations using mutant TP both as a target and as a probe resulted in a significant reduction in number and docking score of the reliable solutions. Indeed, only three reliable solutions over 4,000 could be found, characterized by the same architecture of the predicted dimer of wild-type TP but with significantly higher rank numbers, i.e., 543, 2,388, and 3,324. Collectively, these data suggest that the integrity of H1 is required for the achievement of reliable dimeric architectures. H1, H2, H3, H4 , H5, H6, H7 and H8 are, respectively, blue, orange, green, pink, yellow, cyan, violet and red. IL1 and EL1 are lime, IL2 and EL2 are slate, IL3 and EL3 are salmon and the N-and C-terms are red. In the bottom image, the side chains of the interface amino acids subjected to alanine substitutions are shown in gray computer analysis, with binding parameters as previously reported [37, 41] It has been previously reported that TPb undergoes agonistinduced endocytosis with a kinetics similar to many GPCRs, whereas TPa does so only after prolonged (2-4 h) agonist stimulation, or when co-expressed in the same cells with TPb [4] , or prostacyclin receptor (IP) [7] . These observations suggested that TPa associates with TPb or IP, thus forming hetero-dimeric receptor complexes that undergo agonist-promoted intracellular trafficking. TM1 mutations did not alter the trafficking of individually expressed TPa and TPb in response to agonist stimulation. The addition of 10 -6 M U46619 agonist to HEK293T cells for 60 min caused the internalization of both wild-type and TM1 mutant TPb, whereas both wild-type and TM1 mutant TPa retained their plasma membrane localization (Fig. 2) . When wild-type HA-tagged TPa and Myc-tagged TPb were co-expressed in HEK293T cells, they both localized at the cell surface at steady state, and in intracellular puncta following exposure to 10 -6 M U46619 agonist for 15-60 min (Fig. 3) , thus confirming the co-internalization of TP heterodimers previously reported [4] . Remarkably, after performing the same experiment with the corresponding TM1 mutants, some co-localization of TPa and TPb could be still detected at the membrane of unstimulated cells, but intracellular puncta were uniquely labeled by TPb fluorescence following stimulation with agonist (Fig. 3) . Likewise, the agonist-induced internalization of TM1 TPa did not occur when co-expressed with wild-type TPb, and wild-type TPa failed to internalize when co-expressed with TM1 TPb. These results suggest that independently from which TP member of the co-transfected pair contains the TM1 mutations the TPb-TPa association is impaired and, consequently, also the co-internalization of TPa with TPb.
To obtain direct evidence that TM1 mutations impair TPa-TPb dimerization we performed the FRET analysis by using the laser-induced acceptor bleaching method reported by König et al. [36] . This type of analysis is based on the fact that when energy transfer occurs, the fluorescence emission by the donor fluorochrome is quenched because of the direct transfer of excitation energy to the acceptor fluorochrome. If the acceptor fluorochrome is fully bleached by laser, FRET is blunted and the donor signal is de-quenched, thus resulting in an enhanced fluorescence emission by donor fluorochrome. Thus, HEK293T cells on coverslips were co-transfected with different combinations of wild-type or TM1 mutant HA-TPa and Myc-TPb pairs. Two days after transfection the cells were incubated with anti-epitope antibodies then fixed and exposed to secondary antibodies conjugated to donor and acceptor fluorochromes. Cell samples, imaged under confocal microscope, were subjected to laser-induced bleaching of acceptor fluorescence in defined plasma membrane ROIs. Before and after bleaching donor and acceptor fluorescences were recorded over time. Figure 4 shows that an increase of fluorescence signal emitted by the donor fluorochrome resulting from de-quenching (i.e., FRET signal) was only evident in cells co-expressing the wild-type TPa-TPb pair whereas no increase occurred in cells expressing either the TM1 mutant pair, or one wild-type TP and one TM1 TP. These results suggest that TM1 mutation in either TPa or TPb, is sufficient to undermine hetero-dimerization of the two isoforms. Fig. 2 Cellular localization of recombinant wild-type and TM1 mutant TPa and TPb following cell exposure to agonist. HEK293T cells transiently transfected 48 h before with either wild-type or TM1 mutant HA-tagged TPa or Myc-tagged TPb were exposed to 10 -6 M U46619 agonist for 60 min. After fixation with 4% p-formaldehyde indirect immunofluorescence was performed with anti-tag antibodies and results visualized using laser scanning confocal microscopy. Clearly, wild-type and TM1 mutant TPb undergo agonist-induced internalization upon agonist exposure (arrowheads pointing to intracellular puncta) whereas wild-type and TM1 mutant TPa maintain their localization at the plasma membrane. Scale bar 15 lm. Results are representative of ten fields analyzed for each of three independent experiments Thromboxane A 2 receptor dimerization 3115
Signaling of TPa and TPb wild-type and TM1 mutants
We compared the functional activities of wild-type and TM1 mutant receptors by measuring the U46619 agonistinduced accumulation of IPs in HEK293T cells transiently expressing comparable levels of TP isoforms. Basal IP levels were not significantly different in cells expressing wild-type or TM1 mutant receptors (Table 2) . Also the efficacy of 10 -6 M U46619 to elicit an increased IP accumulation ([10-fold increase over basal) was similar for cells expressing the wild-type or the TM1 mutant receptors. In contrast, computer-assisted analysis of concentrationresponse curves evidenced a 20-fold difference between the EC 50 values of agonist stimulation of wild-type and TM1 mutant TPa (EC 50 wild-type = 12.9 nM ± 20.7%CV; EC 50 TM1 = 210 nM ± 15.7%CV; p \ 0.01) (Fig. 5) . Likewise, U46619 stimulated TM1-TPb at approximately tenfold less potency than wild-type TPb (EC 50 wildtype = 26.5 nM ± 25.7%CV; EC 50 TM1 = 228 ± 12.6) (Fig. 5) .
Discussion
A growing number of in vitro evidence supports the hypothesis that many GPCRs assemble in homo-or heterodimeric/oligomeric complexes [3] . The functional role of such supra-molecular complexes is still unclear and may vary depending on the GPCR type [18, 20] . In particular, for TP, the formation of TPa-TPb and TPa-IP heterodimers in constitutive human systems seems to greatly influence their pharmacological profiles [4] [5] [6] , whereas no data are yet available on the functional significance of TP homodimerization. On the same line, the molecular architecture of either homodimers or heterodimers of TP is still obscure.
In this study, we have employed an integrated approach of in silico and in vitro experiments to infer high-resolution information on TP homodimers and heterodimers, whose existence had been previously reported [4] . In this respect, in vitro experiments were employed to validate a clear inference from computational experiments. The latter relied on quaternary structure predictions of transmembrane proteins, based upon rigid body docking simulations, membrane topology-based filtering, and cluster analysis [31] [32] [33] . Predictions from six independent docking simulations on different structural models of the TPa receptor highlighted the interface essentially characterized by contacts between amino acids distributed along the entire main axis of H1 as the best scored and reliable one (Fig. 1) . Due to the common architecture shared by the members of the rhodopsin GPCR family, extensive H1-H1 contacts would imply also contacts between the C-terminal portion of H8, leading to an H1-H1, H8-H8 dimer (Fig. 1) . Remarkably, such prediction is expected to apply also to TPb homodimers and TPa-TPb heterodimers as the two isoforms share the first 328 amino acids that include all the residues in the predicted interface, expected to perform the bulk of the inter-monomer contacts. Since computational experiments predict that H1 drives TP dimer formation, we engineered a TP mutant characterized by alanine replacements of the TM1 amino acids involved in most of the inter-monomer interface. If quaternary structure predictions were correct, we would expect an impairment of dimerization. In vitro experiments probed the effects of TM1 mutation on TPa-TPb cross-talk. The first validation in this respect came from the observations that wild-type and TM1 TPa did not undergo endocytosis following agonist stimulation when co-expressed with TM1 TPb, as well as wild-type TPa failed to internalize when co-expressed with TM1 TPb (Fig. 3) . The agonist-promoted internalization of wild-type TPa only occurred when co-expressed with wild-type TPb (Fig. 3) [4] . The impairment of TPa internalization when itself or the partner TPb holds the TM1 mutations could arise either from the inability of the TM1 mutant to form hetero-dimeric complex required for TPa to be co-internalized with TPb, or from the mutational disruption of the interaction between TP and unknown protein(s) of the endocytic machinery. The fact that TM1 mutant TPb still retains its ability to internalize and the direct assessment of hetero-dimerization by acceptor photobleaching FRET analysis (Fig. 4) support the view that indeed TM1 mutations in only one member of the pair is enough to impair the association between TPa and TPb. Preliminary experiments showed reduced membrane expression for both TM1 mutant TPa and TPb with respect to their wild-type counterparts (data not shown). A reduced surface expression had been already observed for other TP receptor mutants (Capra et al. [37] and unpublished observations). This can be interpreted as either a reduction in receptor stability, or misfolding, or inability of the mutant receptors to pass the cell quality control, and/or to be efficiently transported to the cell surface [42] . Nonetheless, the mutant TPs that reached the plasma membrane bound the antagonist [ 3 H]-SQ29,548 with normal affinity, and could be activated by the stable TXA 2 agonist U46619 as efficiently as the wild-type receptors at equal level of expression. These data are consistent with the observation that monomeric GPCRs are the minimal functional unit in G protein activation and that dimerization/oligomerization is not absolutely required for this process [9] [10] [11] [12] [13] [14] 43] . However, the U46619 agonist, stimulated TM1 mutant TPa and TPb with a marked reduction in potency, thus suggesting that dimer formation favors a more efficient signaling complex. Since the inter-monomer interface is the same for homodimers and heterodimers, it is expected that there would be no differences in agonist potencies for all dimer types. Indeed, this has already been confirmed by us and others [5] .
Hetero-dimerization is thought to regulate TPa function through agonist-induced internalization. In this respect, given that monomers and homodimers are, presumably, in equilibrium at steady state, it is likely that when a TPa monomer makes complexes with a TPb or IP protomer there would be a shift in the equilibrium from TPa homodimers to monomers with a consequent overall decrease in agonist potency (Fig. 5) , which can be important in cardiovascular homeostasis.
Collectively, the combination of in silico and in vitro experiments indicates that TPa-TPb heterodimers are characterized by H1-H1 contacts. This is consistent with emerging evidence from structure determinations, structure predictions and in vitro experiments on homologous GPCRs, suggesting that H1 is likely to be a privileged mediator of dimerization/oligomerization of these membrane proteins [15, 16, 23, 24, 27, 28, 32] . The architecture of the predicted TP dimers is such that it is likely shared by both TPa and TPb homodimers as well as TPa-TPb heterodimers.
The combined in silico and in vitro approach employed in this study can be adopted to gain structural and functional insights into the dimerization/oligomerization process of all GPCRs for which the structural model of the monomer can be achieved at reasonable atomic resolution. 
